Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2019, Article ID 5350960, 10 pages
https://doi.org/10.1155/2019/5350960
Research Article

Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases

1Grupo de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional (GIRAT), Fundación Valle del Lili and Universidad Icesi, Cali, Colombia
2Blood Bank and Transfusion Service, Fundación Valle del Lili, Cali, Colombia
3Laboratory of Immunology, Fundación Valle del Lili, Cali, Colombia

Correspondence should be addressed to Gabriel J. Tobón; moc.oohay@1nobotg

Received 3 November 2018; Revised 16 January 2019; Accepted 10 February 2019; Published 11 March 2019

Academic Editor: Ricard Cervera

Copyright © 2019 David Aguirre-Valencia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Cottrell, 48 - Mechanisms of Autoimmunity, Elsevier Ltd, 4th edition, 2016.
  2. J. Levy, Plasma Exchange, Elsevier Inc, 5th edition, 2017.
  3. K. Skorecki, G. M. Chertow, P. A. Marsden, M. W. Taal, and A. S. L. Yu, Brenner & Rector's The Kidney, Elsevier, 10th edition, 2016.
  4. J. Schwartz, A. Padmanabhan, N. Aqui et al., “Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the writing committee of the american society for apheresis: the seventh special issue,” Journal of Clinical Apheresis, vol. 31, no. 3, pp. 149–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Ward, “Conventional apheresis therapies: A review,” Journal of Clinical Apheresis, vol. 26, no. 5, pp. 230–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Kaplan, “Therapeutic plasma exchange: A technical and operational review,” Journal of Clinical Apheresis, vol. 28, no. 1, pp. 3–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. G. J. Pons-Estel, G. E. Salerni, R. M. Serrano et al., “Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature,” Autoimmunity Reviews, vol. 10, no. 11, pp. 679–684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. E. Gómez Ortiz, L. F. Pinto Peñaranda, C. Muñoz-Grajales, and J. D. Márquez Hernández, “Plasmaféresis y recambio terapéutico de plasma en enfermedades autoinmunes: indicaciones, complicaciones y desenlaces,” Descripción de una serie de casos. Rev Colomb Reumatol, vol. 21, pp. 139–145, 2014. View at Google Scholar
  9. J. Cid, G. Carbassé, B. Andreu, A. Baltanás, A. Garcia-Carulla, and M. Lozano, “Efficacy and safety of plasma exchange: Ann 11-year single-center experience of 2730 procedures in 317 patients,” Transfusion and Apheresis Science, vol. 51, no. 2, pp. 209–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Mörtzell Henriksson, E. Newman, V. Witt et al., “Adverse events in apheresis: an update of the WAA registry data,” Transfusion and Apheresis Science, vol. 54, no. 1, pp. 2–15, 2016. View at Google Scholar · View at Scopus
  11. M. H. Mokrzycki and A. A. Kaplan, “Therapeutic plasma exchange: complications and management,” American Journal of Kidney Diseases, vol. 23, no. 6, pp. 817–827, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. G. P. Agreda-Vásquez, I. Espinosa-Poblano, S. A. Sánchez-Guerrero et al., “Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective,” Journal of Clinical Apheresis, vol. 23, no. 5, pp. 163–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Daga Ruiz, F. Fonseca San Miguel, F. J. González de Molina, A. Úbeda-Iglesias, A. Navas Pérez, and R. Jannone Forés, “Plasmapheresis and other extracorporeal filtration techniques in critical patients,” Medicina Intensiva, vol. 41, no. 3, pp. 174–187, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Cid, G. Carbassé, M. Gamir, M. Jiménez, E. Arellano-Rodrigo, and M. Lozano, “Acid-base balance disturbances in plasma exchange depend on the replacement fluid used,” Transfusion, vol. 55, no. 11, pp. 2653–2658, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Lara and M. I. Schwarz, “Diffuse alveolar hemorrhage,” CHEST, vol. 137, no. 5, pp. 1164–1171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Cañas, G. J. Tobón, M. Granados, and L. Fernández, “Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus,” Clinical Rheumatology, vol. 26, no. 11, pp. 1947–1949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. U. Martínez-Martínez and C. Abud-Mendoza, “Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus,” Clinical manifestations, treatment, and prognosis. Reumatol Clin, vol. 10, no. 4, pp. 248–253, 2014. View at Publisher · View at Google Scholar
  18. M. R. Zamora, M. L. Warner, R. Tuder, and M. I. Schwarz, “Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome,” Medicine, vol. 76, no. 3, pp. 192–202, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Kim, J. Choi, S.-K. Cho et al., “Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus,” Seminars in Arthritis and Rheumatism, vol. 46, no. 6, pp. 782–787, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Pagnoux, “Plasma exchange for systemic lupus erythematosus,” Transfusion and Apheresis Science, vol. 36, no. 2, pp. 187–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Magro-Checa, E. J. Zirkzee, T. W. Huizinga, and G. M. Steup-Beekman, “Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives,” Drugs, vol. 76, no. 4, pp. 459–483, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Neuwelt, “The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus,” Therapeutic Apheresis and Dialysis, vol. 7, no. 2, pp. 173–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Bartolucci, S. Bréchignac, P. Cohen, V. Le Guern, and L. Guillevin, “Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients,” Lupus, vol. 16, no. 10, pp. 817–822, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Cervera, MA. Khamashta, J. Font et al., “Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients,” in The European Working Party on Systemic Lupus Erythematosus, vol. 72, pp. 113–124, Medicine (Baltimore), 1993. View at Google Scholar
  25. S. Bucciarelli, G. Espinosa, R. Cervera et al., “Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients,” Arthritis & Rheumatology, vol. 54, no. 8, pp. 2568–2576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Uthman, A. Shamseddine, and A. Taher, “The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome,” Transfus Apher Sci, vol. 33, pp. 11–17, 2005. View at Google Scholar
  27. G. E. Westney and E. N. Harris, “Catastrophic antiphospholipid syndrome in the intensive care unit,” Critical Care Clinics, vol. 18, no. 4, pp. 805–817, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Rodríguez-Pintó, M. Moitinho, I. Santacreu et al., “Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry,” Autoimmunity Reviews, vol. 15, no. 12, pp. 1120–1124, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Pagnoux, J.-M. Korach, and L. Guillevin, “Indications for plasma exchange in systemic lupus erythematosus in 2005,” Lupus, vol. 14, no. 11, pp. 871–877, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Li, Y. Wang, Q. Qiu et al., “Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis,” J Clin Apher, vol. 31, pp. 375–380, 2016. View at Publisher · View at Google Scholar
  31. E. J. Lewis, L. G. Hunsicker, S.-P. Lan, R. D. Rohde, and J. M. Lachin, “A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis,” The New England Journal of Medicine, vol. 326, no. 21, pp. 1373–1379, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. M. G. Danieli, C. Palmieri, A. Salvi, M. C. Refe, A. S. Strusi, and G. Danieli, “Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis,” Journal of Clinical Apheresis, vol. 17, no. 2, pp. 72–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Reichrath, G. Bens, A. Bonowitz, and W. Tilgen, “Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients,” Journal of the American Academy of Dermatology, vol. 53, no. 2, pp. 273–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. A. Page, S. Dejardin, C. R. Kahn, R. N. Kulkarni, K. C. Herold, and S. E. Inzucchi, “A patient with type B insulin resistance syndrome, responsive to immune therapy,” Nature Clinical Practice Endocrinology & Metabolism, vol. 3, no. 12, pp. 835–840, 2007. View at Publisher · View at Google Scholar
  35. R. J. Pepper, D. Chanouzas, R. Tarzi et al., “Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 2, pp. 219–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Moussi-Frances, M. Sallée, and N. Jourde-Chiche, “Apheresis to treat systemic vasculitis,” Joint Bone Spine, vol. 85, no. 2, pp. 177–183, 2018. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Walters, N. S. Willis, and J. C. Craig, “Interventions for renal vasculitis in adults,” Cochrane database Syst Rev, vol. 9, Article ID CD003232, 2015. View at Google Scholar
  38. M. Walsh, F. Catapano, W. Szpirt et al., “Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis,” American Journal of Kidney Diseases, vol. 57, no. 4, pp. 566–574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Solar-Cafaggi, Y. Atisha-Fregoso, and A. Hinojosa-Azaola, “Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality,” Journal of Clinical Apheresis, vol. 31, no. 5, pp. 411–418, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Klemmer, W. Chalermskulrat, M. S. Reif, S. L. Hogan, D. C. Henke, and R. J. Falk, “Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis,” American Journal of Kidney Diseases, vol. 42, no. 6, pp. 1149–1153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. R. A. Chaer, M. G. Massad, A. Evans, C. Olopade, and J. Varga, “Systemic sclerosis complicated by diffuse alveolar hemorrhage,” Medical Science Monitor, vol. 7, no. 5, pp. 1013–1015, 2001. View at Google Scholar · View at Scopus
  42. F. Cozzi, P. Marson, M. Rosada et al., “Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity,” Transfusion and Apheresis Science, vol. 25, no. 1, pp. 25–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. F. W. Miller, S. F. Leitman, M. E. Cronin et al., “Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis,” The New England Journal of Medicine, vol. 326, no. 21, pp. 1380–1384, 1992. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Rodriguez-Pla and P. A. Monach, “Primary angiitis of the central nervous system in adults and children,” Rheum Dis Clin North Am, vol. 41, pp. 47–62, 2015. View at Google Scholar
  45. C. Salvarani, R. D. J. Brown, T. J. H. Christianson et al., “Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients,” Arthritis Rheumatol (Hoboken, N.J.), vol. 67, pp. 1637–1645, 2015. View at Google Scholar
  46. J. H. Dominguez and E. Sha, “Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases,” Therapeutic Apheresis, vol. 6, no. 1, pp. 69–76, 2002. View at Publisher · View at Google Scholar · View at Scopus